Preoperative evaluation for a facelift (rhytidectomy) centers on a focused medical history, cardiovascular risk assessment, medication reconciliation, smoking-cessation counseling, and targeted laboratory testing based on each patient’s individual health profile rather than routine panels. A facelift is classified as a low-risk procedure (carrying less than a 1% risk of major adverse cardiovascular events under AHA/ACC consensus), which significantly limits the need for an extensive cardiac workup in otherwise healthy patients. Prior to surgery, each patient completes a detailed health questionnaire that Dr. Namin reviews in advance.
Medical History and Physical Examination
The American Society of Anesthesiologists (ASA) recommends that the pre-anesthesia evaluation include a review of medical records, a patient interview, and a directed physical examination assessing, at minimum, the airway, lungs, and heart, with documentation of vital signs. Key elements include:
- Cardiovascular history: ischemic heart disease, heart failure, arrhythmias, valvular disease, hypertension, and pulmonary hypertension.
- Functional capacity: the ability to perform 4 or more METs of activity (for example, walking up a hill or climbing two flights of stairs) without symptoms.
- Bleeding history: a personal or family history of abnormal bleeding or bruising.
- Comorbidities: diabetes, kidney disease, liver disease, and obesity, the latter being an independent risk factor for adverse events after a facelift.
Smoking Cessation
Smoking is a well-established risk factor for wound-healing complications, skin-flap necrosis, and infection in plastic surgery. A minimum of four weeks of tobacco abstinence before surgery is recommended to reduce pulmonary and wound-healing complications. Many surgeons require complete cessation before an elective facelift, and the preoperative consultation is an important opportunity for long-term cessation counseling.
Blood Pressure Optimization
Hypertension is the most significant modifiable risk factor for postoperative hematoma, the most common complication of facelift surgery. Blood pressure should be well controlled before surgery, and a perioperative blood-pressure management plan is established in advance.
Medication Management
- Antiplatelet agents: Aspirin taken for primary prevention, along with NSAIDs, is generally discontinued 7-10 days before surgery to reduce bleeding risk. For patients on dual antiplatelet therapy after coronary stenting, the decision requires a multidisciplinary discussion weighing thrombotic against bleeding risk.
- Anticoagulants: Typically stopped 48-72 hours before a higher-risk procedure such as a facelift, with bridging therapy considered based on thromboembolic risk.
- Herbal supplements and antidepressants: Many common supplements (such as ginkgo, garlic, ginseng, and fish oil) and certain antidepressants have antiplatelet or hemodynamic effects and are discontinued before surgery.
- ACE inhibitors and ARBs: Generally held the morning of surgery due to the risk of intraoperative low blood pressure.
- GLP-1 agonists (such as Ozempic): These medications slow gastric emptying, so remaining on them through surgery raises the risk of aspiration, a potentially life-threatening event. It is very important to disclose use of these medications to your surgeon before any surgery, so that your surgeon and anesthesia team can develop an individualized safety plan.
- Beta-blockers and statins: Continued through the perioperative period in patients already taking them.
Preoperative Testing
Routine preoperative testing is generally not indicated for healthy patients (ASA class 1-2) undergoing low-risk surgery. Testing is instead directed by the individual’s history:
- ECG: Of little benefit before low-risk cosmetic surgery in patients without cardiovascular disease; reasonable only with known coronary artery disease, arrhythmias, or structural heart disease.
- CBC: Indicated when there is concern for anemia or anticipated significant blood loss.
- Coagulation studies (PT/aPTT): Reserved for patients with a history of bleeding disorders, liver disease, kidney dysfunction, or those on anticoagulants.
- Electrolytes and creatinine: Indicated for patients with chronic kidney disease, diabetes, or on medications that affect electrolytes.
- Glucose / HbA1c: For patients with diabetes or at high risk of undiagnosed diabetes.